Foundation Fighting Blindness Retinal Degeneration Fund - Apr 30, 2025 SCHEDULE 13D/A Report for Opus Genetics, Inc. Common Stock, $0.0001 par value per share (IRD)

Filing Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Reporting Manager
Foundation Fighting Blindness Retinal Degeneration Fund
Security
Opus Genetics, Inc. Common Stock, $0.0001 par value per share
Symbol
IRD
Shares outstanding
59.7M shares
Disclosed Ownership
9.49M shares
Ownership
15.9%
Form type
SCHEDULE 13D/A
Date filed
5/6/2025, 05:55 PM
Date of event
Apr 30, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foundation Fighting Blindness Retinal Degeneration Fund 15.9% 9.49M 0 9.49M /s/ Russell Kelley Russell Kelley, Managing Director 0002042266
Foundation Fight Blindness, Inc. 15.9% 9.49M 0 9.49M /s/ Jason Menzo Jason Menzo, Chief Executive Officer